Journal of Inherited Metabolic Disease
Impact Factor Trend (2018–2026)
Clarivate IF trend for Journal of Inherited Metabolic Disease
SCImago Journal Rank citation prestige weighting
131 papers with at least that number of citations each
Aims & Scope
The Journal of Inherited Metabolic Disease (JIMD) is the official journal of the Society for the Study of Inborn Errors of Metabolism (SSIEM). By enhancing communication between workers in the field throughout the world, the JIMD aims to improve the management and understanding of inherited metabolic disorders. It publishes results of original research and new or important observations pertaining to any aspect of inherited metabolic disease in humans and higher animals. This includes clinical (medical, dental and veterinary), biochemical, genetic (including cytogenetic, molecular and population genetic), experimental (including cell biological), methodological, theoretical, epidemiological, ethical and counselling aspects. The JIMD also reviews important new developments or controversial issues relating to metabolic disorders and publishes reviews and short reports arising from the Society's annual symposia. A distinction is made between peer-reviewed scientific material that is selected because of its significance for other professionals in the field and non-peer- reviewed material that aims to be important, controversial, interesting or entertaining (“Extras”).
Special Issues
Calls for PapersNo active Calls for Papers found for this journal.
WoS Categories & Quartiles
Detailed JCR / JCI category rankings and quartile breakdown from Clarivate
ENDOCRINOLOGY & METABOLISM
GENETICS & HEREDITY
MEDICINE, RESEARCH & EXPERIMENTAL
ENDOCRINOLOGY & METABOLISM
GENETICS & HEREDITY
MEDICINE, RESEARCH & EXPERIMENTAL
Annual Historical Statistics & Publications
Track annual publication volume, total citations, and Impact Factor evolution
SCImago & Scopus Journal Intelligence
Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact
Weighted prestige citation metric per document indexed in the Scopus database.
Average citations received per document published in the 2-year window.
Estimated Article Processing Charge for Open Access publication.
Scopus 3-Year Publication & Citation Window
Aggregated from Scopus database across the 3-year SJR evaluation window.
Societal Impact & Inclusivity (SCImago)
Citations in government and international policy documents
Percentage of female authors published in the journal
Real-world societal policy reach and author gender diversity tracked by SCImago.
Scopus Subject Categories
Journal Metrics & Citation Visualizations
Total Cites vs Self-Cites
Evaluation of scholarly independence and citation reach
Citations per Document
Citation metric windows across 2, 3, and 4 years
Chinese Academy of Sciences (CAS) Classification
Major / minor zone classification and CAS Early Warning List history
Academic Intelligence Overview & Context
ImpaQ AnalysisJournal of Inherited Metabolic Disease (acronym: boli, abbr: J. INHERITED METAB. DIS, ISSN: 0141-8955) is a peer-reviewed international scholarly journal in the field of Medicine, published by Springer Netherlands in Netherlands since 1978. The periodical holds a Journal Impact Factor (JIF) of 3.80, ranking in quartile Q2 of Web of Science (SCIE), a Scopus SJR indicator of 1.401 (Q1), an H-index of 131.
The journal enforces rigorous peer evaluation with a publication frequency of Bimonthly, an annual output of approximately 97 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $3,541 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.
Publishing & Editorial Information
Detailed publisher, peer-review turnaround, and publication cycle specifications
Similar Journals in Discipline
Journals in the same research field with comparable impact metrics